Outcomes of Bebtelovimab Therapy in Patients With Solid Organ Transplantation With Mild and Moderate COVID-19

Solid organ transplant recipients (SOTRs) are at greater risk of poorer outcomes from coronavirus disease 2019 (COVID-19) as compared to the general population. Because of significant drug-drug interactions between nirmatrelvir-ritonavir and immunosuppressive agents as well as logistical challenges...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapur, Rohan, Okumura, Kenji, Feola, Nicholas, Keller, Marina, Dhand, Abhay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259679/
https://www.ncbi.nlm.nih.gov/pubmed/37313067
http://dx.doi.org/10.7759/cureus.38867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259679/
https://www.ncbi.nlm.nih.gov/pubmed/37313067
http://dx.doi.org/10.7759/cureus.38867

Ejemplares similares